GlassScriptPhysician profile
Kou-Wei Chiu
NPI 1912066358
$842.61
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.58 · 2020: $117 · 2021: $261 · 2022: $24.90 · 2023: $165 · 2024: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $160.57 | 2020-2024 | Farxiga, Airsupra |
| Medtronic, INC. | $116.56 | 2021-2023 | Hawkone |
| Abbvie INC. | $103.86 | 2021-2024 | |
| Glaxosmithkline, LLC. | $95.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $52.60 | 2021 | |
| Lilly USA, LLC | $50.77 | 2019-2021 | |
| Dexcom, INC. | $39.51 | 2021-2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $34.74 | 2019 | |
| Novo Nordisk INC | $26.68 | 2020 | |
| Amgen INC. | $24.90 | 2022 | |
| Xeris Pharmaceuticals, INC. | $24.58 | 2023 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.34 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.45 | 2023 | |
| Pfizer INC. | $16.21 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $15.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kou-Wei Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.